Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users
JK Flynn, GJ Dore, M Hellard, B Yeung, WD Rawlinson, PA White, JM Kaldor, AR Lloyd, RA Ffrench
Journal of Viral Hepatitis | WILEY | Published : 2011
Awarded by National Institutes of Health
Awarded by NATIONAL INSTITUTE ON DRUG ABUSE
We thank Geza Paukovics (Burnet Institute) for assistance with flow cytometry, and Tim Spelman (Burnet Institute) for assistance with statistical analysis. We also thank the subjects enrolled in the ATAHC study. This paper is funded by the National Institutes of Health grant R01 DA 15999, and the Australian Government Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. NCHECR is affiliated with the Faculty of Medicine, University of New South Wales. Roche Pharmaceuticals supplied financial support for pegylated IFN gamma-2a/ribavirin.This study was funded by NIH IROIDA 15999-01. JF was supported by an NHMRC PhD Dora Lush scholarship, and MH was supported by NHMRC and VicHealth Fellowships.RF was supported by NHMRC Industry Fellowship. GD was supported by a NHMRC Practitioner Fellowship.